These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 21031399)

  • 1. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
    Milojevic J; Esposito V; Das R; Melacini G
    J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
    Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
    J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers.
    Fawver JN; Duong KT; Wise-Scira O; Petrofes Chapa R; Schall HE; Coskuner O; Zhu X; Colom LV; Murray IV
    J Alzheimers Dis; 2012; 32(1):197-215. PubMed ID: 22785403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
    Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
    J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of amyloid Aβ(1-42) peptide with self-assembled peptide nanospheres.
    Smoak EM; Dabakis MP; Henricus MM; Tamayev R; Banerjee IA
    J Pept Sci; 2011 Jan; 17(1):14-23. PubMed ID: 20814889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the growth, evolution, and self-aggregation of β-amyloid fibrils using tapping-mode atomic force microscopy.
    Serem WK; Bett CK; Ngunjiri JN; Garno JC
    Microsc Res Tech; 2011 Jul; 74(7):699-708. PubMed ID: 21698718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    Kirkitadze MD; Condron MM; Teplow DB
    J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tachykinin neuropeptides on amyloid β aggregation.
    Flashner E; Raviv U; Friedler A
    Biochem Biophys Res Commun; 2011 Apr; 407(1):13-7. PubMed ID: 21352807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
    Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
    Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.